ANPEP and chronic myelogenous leukemia, BCR-ABL1 positive: The inhibition of angiogenesis (or “tube formation” in vitro) is only one obvious aspect, because therapeutic effects of APN inhibitors (ubenimex, actinonin) have also been described for acute or chronic myeloid leukemia (AML, CML) [160,161,162].